Avidity Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
9.74 |
6.83 |
19.55 |
247.47 |
825.05 |
1,329.24 |
| Przychód Δ r/r |
0.00% |
-29.88% |
186.26% |
1165.69% |
233.39% |
61.11% |
| Przychód (min) |
7.46 |
4.36 |
18.87 |
246.43 |
411.59 |
663.12 |
| Przychód (max) |
12.09 |
9.29 |
20.24 |
248.52 |
1,247.21 |
2,009.38 |
| EBITDA (średnia) |
-9.74 |
-6.83 |
-19.55 |
-247.47 |
-825.05 |
-1,329.24 |
| EBIT (średnia) |
-9.74 |
-6.83 |
-19.55 |
-247.47 |
-825.05 |
-1,329.24 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-317.40 |
-440.58 |
-601.37 |
-390.75 |
-52.18 |
258.81 |
| Zysk netto % |
-3258.55% |
-6450.46% |
-3075.68% |
-157.90% |
-6.32% |
19.47% |
| EPS (średnia) |
-2.87 |
-3.95 |
-4.40 |
-3.36 |
-0.47 |
2.32 |
| Liczba analityków (Przychody) |
6 |
8 |
14 |
11 |
4 |
5 |
| Liczba analityków (EPS) |
8 |
11 |
15 |
7 |
5 |
2 |
| symbol |
RNA |
RNA |
RNA |
RNA |
RNA |
RNA |